Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03406455 · ClinicalTrials.gov registry record

Telemedicine in Total Knee Arthroplasty Using Wearable Technology

A clinical trial, sponsored by The Cleveland Clinic.

Completed
Registry status
25
Enrollment target

NCT03406455: Completed study, sponsored by The Cleveland Clinic.

NCT03406455 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03406455 has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
25 participants
Enrollment target

Study Summary

Subjectivity, cost-effectiveness, and inconsistent reporting limit monitoring after total knee arthroplasty (TKA). This prospective study leverages machine learning wearable technology to remotely monitor patients before and after TKA with fidelity and reliability, without sacrificing safe triage needing increased perioperative attention. Patients will download a mobile app that pairs with a "smart" knee sleeve to (1) monitor activity via daily step count, (2) solicit patient-reported outcomes, (3) calculate max flexion, and (4) provide physical therapy compliance data. The primary objective of this study is to determine validity and acceptability of the technology; secondary objectives include perioperative benchmarking with characterization of post-operative recovery trajectories.

Primary Outcome

Semi-structured interviewed

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2018-07-02
Est. Completion 2019-05-15
The Cleveland Clinic

688 total trials

What the finished NCT03406455 record still lists

NCT03406455 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT03406455 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03406455 about?

NCT03406455 is a clinical study titled "Telemedicine in Total Knee Arthroplasty Using Wearable Technology". Subjectivity, cost-effectiveness, and inconsistent reporting limit monitoring after total knee arthroplasty (TKA). This prospective study leverages machine learning wearable technology to remotely monitor patients before and after TKA with fidelity and reliability, without sacrificing safe triage ne...

What is the current status of trial NCT03406455?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2018-07-02. Estimated completion is 2019-05-15.

Who is sponsoring clinical trial NCT03406455?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03406455, the US trial registry maintained by the National Library of Medicine. NCT03406455 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.